GIST-targeted gene panel by Next-Generation sequencing, tumor

Alphabetical Test listing

GIST-targeted gene panel by Next-Generation sequencing, tumor-Pathology add-on

  
GIST-targeted gene panel by Next-Generation sequencing, tumor
  
Pathology add-on
  
GI stromal tumor
GIST
GST9
GST11
GST12
GST13
GST14
GST17
GST18
KIT
Mutation screening
Next Gen Sequencing Test
NGS
Oncology panel
PDGFRA
Tumor panel
  

Diagnosis and management of patients with gastrointestinal stromal tumors

  
Tissue
  

At least 20% tumor is required for this assay. The amount of tissue needed is dependent on a variety of preanalytical factors (eg, cellularity, ischemic time, fixation). In general, the minimum specimen adequacy for this test is approximately a 6 mm 2 area of tissue (can be over multiple slides from one tissue block) or 5,000 total cells (5,000 total nucleated cells if using cytology slides).

  

A pathology report must accompany specimen in order for testing to be performed. Formalin-fixed, paraffin-embedded (FFPE) tissue block (preferred) or 1 slide stained with hematoxylin and eosin and 8 unstained, non-baked slides with 5-microns thick sections of the tumor tissue

  

Formalin-fixed, parrafin-embedded  (FFPE) tissue block

Unused portion of block will be returned

  

 One (1) slide stained with hematoxylin and eosin and ten (10) unstained, non-baked slides with 5-micron thick sections of the tumor tissue with at least 6 mm2 area of tissue (can be over multiple slides) and 20% tumor nuclei, 1 stained and cover-slipped cytology slide with at least 5,000 total nucleated cells and at least 20% tumor cells.

  

Ambient (preferred)

Frozen

Refrigerated

  
Mayo Clinic Laboratories (GISTP): R-NX
  
Mo - Fr, varies
  
12 - 20 days
  

PCR-Based Next Generation Sequencing

  

An interpretive report will be provided

  
81272 - KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)
  
Yes
  
  
06/14/2018
  
11/14/2018